Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association

Cancer Research

Volumn 61, Issue 5, 2001, Pages 1855-1861

  Ellerbroek, Shawn M ^a   Halbleib, Jennifer M ^b   Benavidez, Mario ^b   Warmka, Janel K ^c   Wattenberg, Elizabeth V ^c   Stack, M Sharon ^a   Hudson, Laurie G ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; CANCER INVASION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; METASTASIS; OVARY TUMOR; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADHERENS JUNCTIONS; CELL MEMBRANE; CELL MOVEMENT; DESMOSOMES; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR CELLS, CULTURED;

EID: 0035266290     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Overexpression of the oncogene c-erbB2 in primary ovarian cancer: Evaluation of the prognostic value in a Cox proportional hazards multiple regression
2. The prognostic value of epidermal growth factor mRNA expression in primary ovarian cancer
3. Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors
4. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer
5. EGF/TGF-α and progesterone in urine of ovarian cancer patients
6. Urinary excretion of growth factors in patients with ovarian cancer
7. Malignant transformation of ovarian epithelium
8. Implantation and growth of epidermal growth factor (EGF) receptor expressing human ovarian cancer xenografts in nude mice is dependent on EGF
9. Absence of constitutive EGF receptor activation in ovarian cancer cell lines
10. Epidermal growth factor receptor (EGFR) antisense transfection reduces the expression of EGFR and suppresses the malignant phenotype of a human ovarian cancer cell line
11. Biology and biochemistry of proteinases in tumor invasion
12. Proteinase requirements of epidermal growth factor induced ovarian cancer cell invasion
13. The role of proteolytic enzymes in the pathology of ovarian carcinoma
14. "Proteolytic switching": Opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
15. Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma
16. Experimental metastasis is suppressed in MMP-9-deficient mice
17. Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tissues
18. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors
19. Production of extracellular matrix degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells
20. Sustained activation of the mitogen-activated protein kinase pathway: A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration
21. Elevation of intracellular cyclic adenosine 3′,5′-monophosphate inhibits growth factor mediated matrix metalloproteinase (MMP)-9 induction and keratinocyte migration
22. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes
23. Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: Elevated basal activity and sustained response to EGF
24. Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway
25. Signaling through the lipid products of phosphoinositide-3-OH kinase
26. Signal transduction from multiple ras effectors
27. Phosphoinositide kinases
28. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in Vitro and in Vivo
29. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β)
30. High affinity binding of latent matrix metalloproteinase-9 to the a2(IV) chain of collagen IV
31. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells
32. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD440-mediated tumor invasion
33. Phorbol ester induced cell surface association of matrix metalloproteinase 9 in human MCF10A breast epithelial cells
34. PIK3CA is implicated as an oncogene in ovarian cancer
35. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly
36. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins
37. Differential effects of EGF and amphiregulin on adhesion molecule expression and migration of colon carcinoma cells
38. Invasion and metastasis
39. r 92,000 type IV collagenase secretion and in vitro invasion
40. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells
41. Nucleotide regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK
42. Signalling through phosphoinositide 3-kinases: The lipids take centre stage